Is a Target Hemoglobin A1c Below 7% Safe in Dialysis Patients?

American Journal of Kidney Diseases

Volumn 50, Issue 1, 2007, Pages 166-

  Halevy, Daniel ^a   Vemireddy, Madhavi ^a  

^a ActiveHealth Management   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN; GLYCOSYLATED HEMOGLOBIN;

ANEMIA; CHRONIC KIDNEY DISEASE; CLINICAL PROTOCOL; COMORBIDITY; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; HEMODIALYSIS; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; KIDNEY FUNCTION; LETTER; NUTRITIONAL ASSESSMENT; PERFORMANCE MEASUREMENT SYSTEM; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SURVIVAL; BLOOD; CHRONIC KIDNEY FAILURE; NOTE; PRACTICE GUIDELINE; REFERENCE VALUE; RENAL REPLACEMENT THERAPY;

DIABETES COMPLICATIONS; DIABETES MELLITUS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; PRACTICE GUIDELINES; REFERENCE VALUES; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC;

EID: 34250784428     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2007.05.006     Document Type: Letter

References (3)

1. National Kidney Foundation. KDOQI clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease. Am J Kidney Dis 49 suppl 2 (2007) S1-S180
2. Williams M.E., and Lazarus J.M. Hemodialyzed type I and type II diabetic patients in the US: Characteristics, glycemic control, and survival. Kidney Int 70 (2006) 1503-1509
3. Pogach L.M., and Sawin C.T. Development of evidence-based clinical practice guidelines for diabetes: the Department of Veterans Affairs/Department of Defense guidelines initiative. Diabetes Care 27 suppl 2 (2004) B82-B89